Consensus Report on Automated Insulin Delivery Systems Released
The European Association for the Study of Diseases and the American Diabetes Association jointly published a consensus report on the benefits, challenges, and recommendations for use of automated insulin delivery systems—an umbrella term referring to administration systems that incorporate continuous glucose monitoring, insulin dose adjustment algorithms, and an insulin pump to automate subcutaneous insulin delivery. Read more.

Studying Pharmacists’ Impact on Immunization Administration
During the COVID-19 pandemic, pharmacists took a leading role and spearheaded national vaccination efforts. Depending on the state, pharmacists have had immunizer status for years; however, data are limited on the impact of pharmacist involvement on immunization uptake and outcomes. Researchers conducted a study to explore the impact of pharmacist involvement related to vaccine uptake. Read more.

Barriers, Opportunities for Pharmacists in Treating Opioid Use Disorder
The opioid crisis had already existed prior to the COVID-19 pandemic. However, the social restrictions associated with the pandemic have contributed to an increase in illicit opioid use. While only those deemed “qualified providers” are able to prescribe buprenorphine, pharmacists can still play a role in assisting patients with medications for opioid use disorder. Read more.